Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
SentreHeart said it won FDA investigational device exemption approval to begin enrolling subjects in a clinical trial of its Lariat device.
The Amaze trial will evaluate the use of the Lariat for the ligation of the left atrial appendage as an adjunctive treatment to ablation in patients with persistent atrial fibrillation, the company said. Read more
Medtronic said that it won FDA approval for its Advisa SR MRI-safe SureScan single-chamber pacemaker, and that it is launching the device in the U.S.
The device will allow MRI scans of any region of the body as long as it is used with MRI-safe SureScan leads, the Fridley, Minn.-based company said. Read more
Sorin Group and Cyberonics said that LivaNova will be the new name for the merged companies.
The companies said the name was chosen through a combination of market research and employee participation from both Sorin and Cyberonics. Read more